Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Hashimoto

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Cancer Medicine|April 18, 2025
A Real-Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune-Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus IpilimumabAtsuto Mouri, Hisao Imai, Satoshi Endo, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational StudyYuhei Kurata, Atsuto Mouri, Hisao Imai, et al.
Scientific Reports|October 23, 2020
Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stagesAyumi Taguchi, Kazunori Nagasaka, Charles Plessy, et al.
Biochemical and Biophysical Research Communications|December 15, 2022
Lipid droplet accumulation and adipophilin expression in follicular thyroid carcinomaMichiyo Hayakawa, J Nicholas Taylor, Ryuta Nakao, et al.
Oncology|August 5, 2024
The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung CancerSatoshi Endo, Hisao Imai, Ayako Shiono, et al.
Nature Communications|March 28, 2026
The CD4<sup>+</sup> T cell population partners with Tpex CD8<sup>+</sup> T cells to mediate antitumor immunity in the tumor microenvironmentShota Takei, Satoshi Yamasaki, Ou Yamaguchi, et al.
Developmental Cell|September 3, 2019
Broad Heterochromatic Domains Open in Gonocyte Development Prior to De Novo DNA MethylationSoichiro Yamanaka, Hidenori Nishihara, Hidehiro Toh, et al.
Carcinogenesis|November 7, 2015
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stressAli Tebbi, Florence Levillayer, Grégory Jouvion, et al.
Cancer Immunology Research|December 25, 2019
CD4<sup>+</sup> T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 TherapyHiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi, et al.
Cancer Reports (Hoboken, N.J.)|July 28, 2022
Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa-associated lymphoid tissue lymphoma: A case reportAyako Shiono, Hisao Imai, Tsugumi Satou, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Cancer Medicine|April 18, 2025
A Real-Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune-Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolumab Plus IpilimumabAtsuto Mouri, Hisao Imai, Satoshi Endo, et al.
Medicina (Kaunas, Lithuania)|June 27, 2025
Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observational StudyYuhei Kurata, Atsuto Mouri, Hisao Imai, et al.
Scientific Reports|October 23, 2020
Use of Cap Analysis Gene Expression to detect human papillomavirus promoter activity patterns at different disease stagesAyumi Taguchi, Kazunori Nagasaka, Charles Plessy, et al.
Biochemical and Biophysical Research Communications|December 15, 2022
Lipid droplet accumulation and adipophilin expression in follicular thyroid carcinomaMichiyo Hayakawa, J Nicholas Taylor, Ryuta Nakao, et al.
Oncology|August 5, 2024
The Glasgow Prognostic Score as a Predictor of Survival after Chemoradiotherapy for Limited-Disease Small Cell Lung CancerSatoshi Endo, Hisao Imai, Ayako Shiono, et al.
Nature Communications|March 28, 2026
The CD4<sup>+</sup> T cell population partners with Tpex CD8<sup>+</sup> T cells to mediate antitumor immunity in the tumor microenvironmentShota Takei, Satoshi Yamasaki, Ou Yamaguchi, et al.
Developmental Cell|September 3, 2019
Broad Heterochromatic Domains Open in Gonocyte Development Prior to De Novo DNA MethylationSoichiro Yamanaka, Hidenori Nishihara, Hidehiro Toh, et al.
Carcinogenesis|November 7, 2015
Deficiency of multidrug resistance 2 contributes to cell transformation through oxidative stressAli Tebbi, Florence Levillayer, Grégory Jouvion, et al.
Cancer Immunology Research|December 25, 2019
CD4<sup>+</sup> T-cell Immunity in the Peripheral Blood Correlates with Response to Anti-PD-1 TherapyHiroshi Kagamu, Shigehisa Kitano, Ou Yamaguchi, et al.
Cancer Reports (Hoboken, N.J.)|July 28, 2022
Metachronous lesions in the orbit, retroperitoneum, and pleura of mucosa-associated lymphoid tissue lymphoma: A case reportAyako Shiono, Hisao Imai, Tsugumi Satou, et al.
Pageof 14